NCT02684539

Brief Summary

syncope prediction on tilt table

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2014

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2014

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

November 27, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 18, 2016

Completed
Last Updated

October 4, 2019

Status Verified

October 1, 2019

Enrollment Period

8 months

First QC Date

November 27, 2015

Last Update Submit

October 3, 2019

Conditions

Syncope

Outcome Measures

Primary Outcomes (1)

  • clinical sign of syncope

    as diagnosed by the medical staff

    1 session of 90 minutes duration

Study Arms (1)

tilt table Erigo®

EXPERIMENTAL

observation of physiological parameters, tilting table with onset of syncope

Device: tilt table Erigo®

Interventions

tilt table Erigo®DEVICE

tilting table with onset of syncope

tilt table Erigo®

Eligibility Criteria

Age18 Years - 49 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • healthy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Syncope

Condition Hierarchy (Ancestors)

UnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2015

First Posted

February 18, 2016

Study Start

April 1, 2014

Primary Completion

December 1, 2014

Study Completion

December 1, 2014

Last Updated

October 4, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share